ARQT - Arcutis Biotherapeutics Inc
24.59
-0.230 -0.935%
Share volume: 973,183
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$24.82
-0.23
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-06-2024 | 02-25-2025 | 05-06-2025 | 10-28-2025 | 02-25-2026 | |
| Cash flow financing | 161.764 M | 1.455 M | 394.000 K | -97.411 M | 395.000 K | 1.476 M | 3.722 M | |
| Other financing cash flows | 82.000 K | 806.000 K | 394.000 K | 1.525 M | 395.000 K | 1.476 M | 2.665 M | |
| Cash flow | 101.464 M | -105.801 M | 50.483 M | -63.282 M | -18.235 M | -25.525 M | -4.272 M | |
| Net income | -35.382 M | -52.332 M | -41.537 M | -10.788 M | -25.060 M | 7.410 M | 17.395 M | |
| Depreciation | 170.000 K | 164.000 K | 161.000 K | 145.000 K | 153.000 K | 0.000 | 0.000 | |
| Changes in inventories | 113.000 K | 0.000 | 0.000 | 0.000 | 1.951 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -28.697 M | -62.137 M | 84.777 M | 34.877 M | 11.750 M | -25.247 M | -34.179 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 143.000 K | 0.000 | 608.000 K | 0.000 | 0.000 | |
| Cash Change | 101.391 M | -105.827 M | 50.581 M | -63.516 M | -18.231 M | -25.620 M | -4.213 M |